Related Experiment Video
Updated: Sep 11, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Diabetes Technology and the Older Adult: Clinical Outcomes and Implementation Strategies
Kenyin Loo Urbina1, Christine Slyne2, Medha N Munshi3
1Hospital Clínico Universidad de Chile, Department of Diabetes, Santiago, Chile.
Abstract:
The prevalence of diabetes among older adults continues to rise. Aging brings unique challenges to the management of diabetes in older adults, as treatment goals and patients' ability to reach those goals depend on overall health status and support systems, which can change frequently in this population. In addition, hypoglycemia has severe consequences in the older population and remains a limiting factor in our ability to improve glycemic control. Recent advancements in diabetes technology-such as smart insulin pens, continuous glucose monitoring, and hybrid closed-loop insulin pump systems-offer improved glycemic control and reduced risk of hypoglycemia in all adults, although available evidence often excludes older adults with frailty or cognitive impairment. Recent studies of technology use in relatively healthy older adults have demonstrated benefits, including higher time in range, less severe hypoglycemia, and enhanced satisfaction. Careful patient selection, comprehensive education, and caregiver support are crucial to the successful use of technology by older adults with diabetes. By applying a geriatric-focused approach, which balances modern technology with the individual's functional status, cognition, and comorbidities, clinicians can optimize safety and efficacy in managing diabetes in older adults. This approach should be applied regardless of diabetes type or the patient's degree of frailty.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

